Sarawak takes centre stage as Hydrogen Economy Forum 2025 opens today
KUCHING (May 13): Sarawak is taking centre stage in the global hydrogen agenda with bold ambition and strategic clarity as the Hydrogen Economy Forum (H2EF) 2025 kicks off today, calling for international collaboration, innovation, and climate action.
Sarawak Deputy Minister of Energy and Environmental Sustainability Dr Hazland Abang Hipni, who is also H2EF 2025 chairperson, said the forum marks a pivotal moment as the world grapples with the twin forces of climate crisis and rapid technological change.
'Hydrogen has emerged not just as an alternative energy source, but as a transformative solution.
'It is changing the way we think about energy — how we produce it, how we store it and how we utilise it.
'Its potential to fuel cleaner, more resilient and more inclusive economies is extraordinary, and we are only just beginning,' he said during his opening speech at a hotel here today.
Dr Hazland highlighted Sarawak's strategic advantages — its vast landmass, rich biodiversity, and abundant hydropower potential — as key factors in its emergence as a regional hydrogen hub.
He noted that 62 per cent of the state's 12.5 million hectares remain forested, with more than 300 rivers offering untapped opportunities for renewable energy development, including floating solar projects with a projected potential of up to three gigawatts.
Dr Hazland credited Sarawak's leadership under Premier Datuk Patinggi Tan Sri Abang Johari Tun Openg for its bold vision and political will to explore green technologies through the state's Post-covid Development Strategy 2030 and four-pronged policy framework — covering legal, technical, financial, and human resources talent development.
'This forum is more than a conference. It is a platform for ambition, collaboration, and action.
'Sarawak is ready to lead, to partner, and to shape a sustainable hydrogen future,' he added.
H2EF 2025 is jointly organised by the Ministry of Energy and Environmental Sustainability Sarawak (MEESty), the Ministry of Science, Technology and Innovation Malaysia (Mosti), and Borneo Business Connect, with the support of Business Events Sarawak (BESarawak).
The two-day forum features high-level dialogues, cross-border partnerships, and in-depth sessions on hydrogen production, financing, policy frameworks, certification, and global logistics. Datuk Dr Hazland Abang Hipni Hydrogen Economy Forum 2025 lead
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
5 hours ago
- The Sun
Global M&As surpass US$2.6 trillion year to date
LONDON: Global dealmaking has reached US$2.6 trillion (RM11 trillion), the highest for the first seven months of the year since the 2021 pandemic-era peak, as a quest for growth in corporate boardrooms and the impact of a surge in AI activity has overcome the uncertainty caused by US tariffs. The number of transactions to Aug 1 is 16% lower than the same time last year, but their value is 28% higher, according to Dealogic data, boosted by US megadeals valued at more than US$10 billion. They include Union Pacific Corp's proposed US$85 billion acquisition of small rival Norfolk Southern and OpenAI's US$40 billion funding round led by Softbank Group. The upsurge will be a relief to bankers who began the year with expectations the administration of US President Donald Trump would lead to a wave of consolidation. Instead, his trade tariffs and geopolitical uncertainty made companies pause until renewed confidence in corporate boardrooms and the US administration's anti-trust agenda changed the mood. 'What you're seeing in terms of deal rationale for transactions right now is that it's heavily growth-motivated, and it's increasing,' Andre Veissid, EY Global Financial Services Strategy and Transactions Leader, told Reuters. 'Whether it's artificial intelligence (AI), the change in the regulatory environment, we see our clients not wanting to be left behind in that race and that's driving activity.' Compared with August 2021, when investors, rebounding from pandemic lockdowns drove the value of deals to US$3.57 trillion, this year's tally is nearly a US$1 trillion, or 27%, lower. Still, deal-makers at JP Morgan Chase have said there is more to come, with companies pursuing bigger deals in the second half of the year as executives adapt to volatility. 'People have got used to the prevailing uncertainty, or maybe the unpredictability post-US election is just more predictable now,' Simon Nicholls, co-head of Slaughter and May Corporate and M&A group, said. Nigel Wellings, partner at Clifford Chance said the market was moving beyond tariffs. 'Boardrooms are seeing the M&A opportunity of a more stable economic environment and positive regulatory signals. But it is not a frothy market.' While the healthcare sector drove M&A in the years after the pandemic, the computer and electronics industry has produced more takeover bids in the US and the UK in the last two years, according to Dealogic. Artificial intelligence is expected to drive more dealmaking. M&A activity has increased around data centre usage, such as Samsung's US$1.7 billion acquisition of Germany's FlaktGroup, a data centre cooling specialist. Palo Alto Networks US$25 billion deal for Israeli cybersecurity peer CyberArk was the largest deal in Europe, Middle East and Africa so far this year as rising AI-driven threats push companies to adopt stronger defences. Private equity, which had been sitting on the sidelines, has once again been active, with Sycamore Partners' US$10 billion deal to take private Walgreens Boots Alliance and rivalling £4.8 billion (RM27 billion) offers from KKR and Advent for UK scientific instrument maker Spectris. The US was the biggest market for M&A, accounting for more than half of the global activity. Asia Pacific's dealmaking doubled over the same year to date period last year, outpacing the EMEA region.
New Straits Times
12 hours ago
- New Straits Times
Trump scores major own goal with labour official firing
US President Donald Trump's decision to fire a top labour official following weak jobs data obviously sends ominous signals about political interference in independent institutions, but it is also a major strategic own goal. Trump has spent six months attacking the Federal Reserve, and Chair Jerome Powell in particular, for not cutting interest rates. The barbs culminated in Trump branding Powell a "stubborn MORON" in a social media post on Friday before the July jobs report was released. The numbers, especially the net downward revision of 258,000 for May and June payrolls growth, were much weaker than expected. In fact, this was "the largest two-month revision since 1968 outside of NBER-defined recessions (assuming the economy is not in recession now)," according to Goldman Sachs. This release sparked a dramatic reaction in financial markets. Fed rate cut expectations soared, the two-year Treasury yield had its steepest fall in a year, and the dollar tumbled. A quarter-point rate cut next month and another by December were suddenly nailed-on certainties, according to rate futures market pricing. This was a huge U-turn from only 48 hours before when Powell's hawkish steer in his post-FOMC meeting press conference raised the prospect of no easing at all this year. Trump's constant lambasting of "Too Late" Powell suddenly appeared to have a bit more substance behind it. The Fed chair's rate cut caution centres on the labour market, which now appears nowhere near as "solid" as he thought. Trump could have responded by saying: "I was right, and Powell was wrong." Instead, on Friday afternoon he said he was firing the head of the Bureau of Labour Statistics, Commissioner Erika McEntarfer, for faking the jobs numbers. Trump provided no evidence of data manipulation. So rather than point out that markets were finally coming around to his way of thinking on the need for lower interest rates, Trump has united economists, analysts and investors in condemnation of what they say is brazen political interference typically associated with underdeveloped and unstable nations rather than the self-proclaimed 'leader of the free world'. "A dark day in, and for, the US," economist Phil Suttle wrote on Friday. "This is the sort of thing only the worst populists do in the worst emerging economies and, to use the style of President Trump, IT NEVER ENDS WELL." It's important to note that major – even historic – revisions to jobs growth figures are not necessarily indicative of underlying data collection flaws. As Ernie Tedeschi, director of economics at the Budget Lab at Yale, argued on X over the weekend: "BLS's first-release estimates of nonfarm payroll employment have gotten more, not less, accurate over time." It should also be noted that the BLS compiles inflation as well as employment data, so, moving forward, significant doubt could surround the credibility of the two most important economic indicators for the US - and perhaps the world. Part of what constitutes "US exceptionalism" is the assumption that the experts leading the country's independent institutions are exactly that, independent, meaning their actions and output can be trusted, whatever the results. Baseless accusations from the US president that the BLS, the Fed and other agencies are making politically motivated decisions to undermine his administration only undermine trust in the US itself. "If doubts are sustained, it will lead investors to demand more of a risk premium to own US assets," says Rebecca Patterson, Senior Fellow at the Council on Foreign Relations. "While only one of many forces driving asset valuations, it will limit returns across markets." This furor comes as Fed Governor Adriana Kugler's resignation on Friday gives Trump the chance to put a third nominee on the seven-person Fed board, maybe a potential future chair to fill that slot as a holding place until Powell's term expires in May. Whoever that person is will likely be more of a policy dove than a hawk. Policy uncertainty, which had been gradually subsiding since the April 2 'Liberation Day' tariff turmoil, is now very much back on investors' radar.
Focus Malaysia
a day ago
- Focus Malaysia
Medical device sector thrives with trade surplus, growing foreign investment
MALAYSIA has a strong exporting power for medical devices. Unlike pharmaceuticals, Malaysia is largely a net exporter of medical devices. These are mainly consumables, diagnostics equipment and patient aids. Imports, meanwhile, shown a steady growth, a signal that Malaysia's healthcare demand for advanced medical technologies and equipment continue to grow. Malaysia consistently maintains a significant trade surplus in medical devices, highlighting the medical device sector as a key contributor to Malaysia's overall trade balance. While gloves constituted a large portion of the total medical device exports, non-glove exports overtook the total export for 2022 onwards. This shift is crucial as it indicates that Malaysia's efforts to diversify its medical device manufacturing base beyond gloves are bearing fruit. The significant growth in non-glove exports means the industry is becoming more resilient and less dependent on a single product category. This aligns with national goals of strengthening innovation capacity and moving up the value chain. As of quarter one of 2025, the total investment value in medical devices reached RM26.3 mil, spread across about 180 projects. Foreign investments had a slight upper hand in the medical devices' investment landscape, notably during post-Covid. This may suggest that, as global supply chains had normalized, foreign companies re-engaged with investment plans in Malaysia. The swings between DDI and FDI dominance also reflects specific government incentives in healthcare investments, promising global economic conditions for the subsector, and strategic shifts by both local and international players. On average, FDI dominated at 52.2% of the total investments. AI-based equipment and devices are expected to see a surge in demand, with market size projected to grow up to USD220 mil by 2030, at a very high five year compounded annual growth rate of 45.4%. The Malaysian Investment Development Authority (MIDA) had taken significant steps to include AI technology under its medical devices' regulations. The AI must be a medical device that uses machine learning (ML), in part or in whole, to achieve its intended medical purpose. The AI is expected to be under the jurisdiction of Section 2 of the Medical Device Act 2012 (Act 737). We believe this update to the regulatory framework is timely, aligning with the government's National Health Missions, Healthcare White Paper and NIMP 2030, as well the rapid growth in AI utilization in everyday life. Other drivers include: (i) Increasing healthcare data volume. (ii) Shortage of skilled healthcare professionals. (iii) Growing demand for cost reduction and operational efficiencies. (iv) Increased focus on personalized and preventive healthcare. While traditional clinical data remains paramount, there is a clear and accelerating trend in integration between data and technology, aiming towards incorporating real-world data from remote care, advanced 'omics' technologies for personalized insights, and external factors that shape an individual's health. This multi-faceted approach to data collection and analysis is crucial for developing more proactive, preventive, and personalized model. The ability to collect, integrate, and analyse these diverse data streams is paving the way for precision health, predictive analytics and more. However, the trends clearly indicate a future where digital data will be the bedrock of a more intelligent, efficient, and patient-centred healthcare system. —Aug 4, 2025 Main image: Stanton Chase
